Top Markets
Coin of the day
Cardiol Therapeutics Inc. Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc.

CRDL
Classement en actions #17273
Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company,... Cardiol Therapeutics Inc. operates as a clinical-stage life sciences company, primarily engaged in the discovery and advancement of treatments designed to combat fibrosis and inflammation within the context of cardiovascular diseases. Its flagship product, CardiolRx, is currently undergoing a significant Phase II/III international clinical trial. This extensive study is randomized, double-blind, and placebo-controlled, evaluating CardiolRx's efficacy and safety as a heart-protective therapy to mitigate cardiovascular and respiratory issues in individuals hospitalized with COVID-19. Concurrently, the trial also assesses CardiolRx's role in addressing acute myocarditis. Beyond this, the company is developing an injectable, subcutaneous formulation of CardiolRx, intended to target cardiac scarring and inflammation that contribute to the development and worsening of heart failure. Established in 2017, Cardiol Therapeutics Inc. is based in Oakville, Canada.
Prix de l'action
$2.17
Capitalisation boursière
$249.58M
Changement (1 jour)
-1.67%
Changement (1 an)
96.34%
Pays
CA
Échange Cardiol Therapeutics Inc. (CRDL)

Catégorie

Historique du prix de l'action pour Cardiol Therapeutics Inc. (CRDL)
Prix de clôture le plus élevé : $2.18 le 2026-09-01

Prix de clôture le plus bas : $3.27 le 2018-12-01
Historique du prix de l'action de Cardiol Therapeutics Inc. de 2018 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) 17.15%
2025 -27.01%
2024 53.46%
2023 55.10%
2022 -70.87%
2021 -2.95%
2020 -34.16%
2019 -4.78%
2018 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$171.67 -
DE
$165.17 31.41%
DE
$38.13 25.43%
JP
$21.28 19.62%
IN
$214.98 26.11%
CH